CDKN1B and cancer: Studies have shown a strong correlation between low p27 expression levels and poor prognosis in various cancers.305 Overall, the data from primary tumors suggest that hyperactivation of CDK2 is strongly associated with tumor progression and is generally related to functional deregulation rather than its direct genomic abnormalities.